Evaluation of tear function tests and corneal thickness in patients with meibomian gland dysfunction
Abstract
Objectives: To investigate whether central corneal thickness (CCT) and tear function test differ from healthy controls in the ones suffering meibomian gland dysfunction (MGD).
Methods: This prospective study was carried out with 99 individuals in total (50 patients MGD, 49 healthy individuals). Schirmer-1, tear break-up time (TBUT), the Ocular Surface Disease Index (OSDI) questionnaire and CCT measurmentwas administered to all patients.
Results: The average Schirmer 1 measurements were 16.6 ± 3.3 mm for right eyes, 16.4 ± 3.6 mm for left eyes in the MGD group and 17.1 ± 3.7 mm for right eyes, 17.0 ± 4.4 mm for left eyes in the control group. The mean TBUT values were 10.1 ± 3.6 seconds for right eyes, 10.2 ± 3.4 seconds for left eyes in the MGD group and 14.7±3.7 seconds for right eyes, 15.8 ± 4.1 seconds for left eyes in the control group (p = 0.001). The mean OSDI score values were 40.3 ± 23.7 in the MGD group and 19.4 ± 8.7 in the control group (p = 0.001). The average CCT in the MGD group was 539.4 ± 30.0 µm and 539.7 ± 33.0 µm (right and left, respectively). The average CCT in the control group was 551.6 ± 32.8 µm and 550.7 ± 32.2 µm (right and left, respectively). The mean CCT measurements in the MGD group were not statistically significant compared to the healthy control group (p = 0.059, and p = 0.097, right and left, respectively).
Conclusions: The Schirmer test and CCT measurements are not significantly different in patients with MGD compared to healthy control subjects.
Keywords
References
- 1. Greiner JV, Glonek T, Korb DR, Whalen AC, Hebert E, Hearn SL, et al. Volume of the human and rabbit meibomian gland system. In: Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. Springer, Boston: MA; 1998: pp. 339-43.
- 2. Mishima S, Maurice DM. The oily layer of the tear film and evaporation from the corneal surface. Exp Eye Res 1961;1:39-45.
- 3. Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011;52:1922-9.
- 4. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf 2004;2:149-65.
- 5. Lemp MA, Nichols KK. Blepharitis in the United States, a survey-based perspective on prevalence and treatment. Ocul Surf 2009;7:1-14.
- 6. Blackie CA, Korb DR, Knop E, Bedi R, Knop N, Holland EJ. Nonobvious obstructive meibomian gland dysfunction. Cornea 2010;29:1333-45.
- 7. Nicolaides N, Kaitaranta JK, Rawdah TN, Macy JI, Boswell FM 3rd, Smith RE. Meibomian gland studies: comparison of steer and human lipids. Invest Ophthalmol Vis Sci 1981;20:522-36.
- 8. Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye (Lond) 1991;5:395-411.
Details
Primary Language
English
Subjects
Ophthalmology
Journal Section
Research Article
Publication Date
November 4, 2020
Submission Date
April 29, 2019
Acceptance Date
February 6, 2020
Published in Issue
Year 1970 Volume: 6 Number: 6